Dr. Niven R. Narain is President and CEO of BPGbio Inc, a leading AI-powered, biology-focused biopharma company in Boston, MA. He is recognized as a pioneer in the intersection of Biology and AI and led the development the NAi Interrogative Biology® platform which has fueled an advanced late-stage pipeline of assets in Oncology, CNS, and rare inflammatory diseases. He was previously the Co-founder, President and CEO of BERG Health and led the acquisition by BPGbio in January 2023 raising over $400mm over a decade.

An industry thought leader with over 20 years of experience in drug development, precision medicine, and AI/ML, Dr. Narain has served as a frequent speaker at Economist, Bloomberg, Financial Times, Wired, and Aspen Ideas in addition to many international meetings on medicine and technology and his discoveries cover over 450 patents globally.  He is a member of the NASA/Gene Lab Steering Committee, advisor to US (DoD) leadership on breast and prostate cancer, the School of Applied Computational Sciences at Meharry Medical College, the Oral Cancer Foundation, and has forged strategic partnerships with industry, academia, and governments. He also serves on the Advisory Board for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School and the Healthy Aging Commission at No. 10., and the Ditchley Foundation.

Dr. Narain was named to the Boston Business Journal top 40 leaders under 40 (2014), an EY Entrepreneur of Year finalist (2018), Deep Knowledge Analytics Top 100 AI Pioneers (2019), Top 10 Transformative CEO’s by The CEO Forum (2020) and the PharmaVoice Top 100 (2024). He has been featured on CNN, BBC, CNBC, FORBES, Fox News, The New York Times, and the Wall Street Journal.

Dr. Narain obtained a B.S. in Biological Sciences from St. John’s University, NY and a Ph.D. in Biochemistry/Cancer Biology at the University of Miami Miller School of Medicine where went on to do a clinical fellowship in cutaneous oncology, later serving as Director of Cutaneous Oncology research in the Department of Dermatology & Cutaneous Surgery where he is still on Faculty. His work has been published in Nature Medicine, Science Translational Medicine, and Cell with leading collaborators from academia, NIH, and the DOD.

Dr. Narain is most passionate about improving patient care and enabling increased access to innovative medicines towards improved health care outcomes. He is active in educational programs for STEM programs in Massachusetts and is on the Vestry of the Trinity Episcopal Church – Boston while participating in many mission trips to the Caribbean and Africa.